These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2483024

  • 1. Benzyl alcohol alters the hemoglobin phenotype of mouse erythroleukemia cells.
    Scher W, Scher BM, Hellinger N, Waxman S.
    J Biol Regul Homeost Agents; 1989; 3(3):91-7. PubMed ID: 2483024
    [Abstract] [Full Text] [Related]

  • 2. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S, Scher BM, Hellinger N, Scher W.
    Cancer Res; 1990 Jul 01; 50(13):3878-87. PubMed ID: 2354439
    [Abstract] [Full Text] [Related]

  • 3. A possible effect of heme on the fate of DNA ligase activity extracted from differentiating mouse erythroleukemia cells.
    Scher BM, Scher W, Waxman S.
    Cancer Res; 1988 Nov 15; 48(22):6278-84. PubMed ID: 3180046
    [Abstract] [Full Text] [Related]

  • 4. Alterations in electrophoretic mobility, diaphorase activity, and terminal differentiation induced in murine erythroleukemia lines by differentiating agents.
    Gascoyne PR, Becker FF.
    J Cell Physiol; 1990 Feb 15; 142(2):309-15. PubMed ID: 2303526
    [Abstract] [Full Text] [Related]

  • 5. Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases.
    Watanabe T, Kondo K, Oishi M.
    Cancer Res; 1991 Feb 01; 51(3):764-8. PubMed ID: 1988116
    [Abstract] [Full Text] [Related]

  • 6. Effect of dexamethasone on hexamethylene bisacetamide-induced Friend cell erythrodifferentiation.
    Osborne HB, Bakke AC, Yu J.
    Cancer Res; 1982 Feb 01; 42(2):513-8. PubMed ID: 6173113
    [Abstract] [Full Text] [Related]

  • 7. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K, Poindessous-Jazat V, Augery-Bourget Y, Hanania N, Robert-Lézénès J.
    Cell Death Differ; 1999 Feb 01; 6(2):166-74. PubMed ID: 10200563
    [Abstract] [Full Text] [Related]

  • 8. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
    Corin RE, Haspel HC, Peretz AM, Sonenberg M, Rifkind RA.
    Cancer Res; 1986 Mar 01; 46(3):1136-41. PubMed ID: 3455880
    [Abstract] [Full Text] [Related]

  • 9. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA, Rifkind RA.
    Int J Cell Cloning; 1988 Jul 01; 6(4):230-40. PubMed ID: 3047266
    [Abstract] [Full Text] [Related]

  • 10. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
    Fibach E, Reuben RC, Rifkind RA, Marks PA.
    Cancer Res; 1977 Feb 01; 37(2):440-4. PubMed ID: 264411
    [Abstract] [Full Text] [Related]

  • 11. Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells.
    Sherman ML, Shafman TD, Kufe DW.
    J Cell Physiol; 1988 Mar 01; 134(3):429-36. PubMed ID: 2450878
    [Abstract] [Full Text] [Related]

  • 12. Amiloride in differentiation and commitment of Friend erythroleukemia cells.
    Lubin M.
    J Cell Physiol; 1985 Sep 01; 124(3):539-44. PubMed ID: 3862669
    [Abstract] [Full Text] [Related]

  • 13. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
    Okafuji K, Kaku K, Seguchi M, Tanaka H, Azuno Y, Kaneko T.
    Exp Hematol; 1995 Mar 01; 23(3):210-6. PubMed ID: 7875239
    [Abstract] [Full Text] [Related]

  • 14. Depletion of sodium butyrate from the culture medium of Friend erythroleukemia cells undergoing differentiation.
    Friend C, Zajac-Kaye M, Holland JG, Pogo BG.
    Cancer Res; 1987 Jan 15; 47(2):378-82. PubMed ID: 3466690
    [Abstract] [Full Text] [Related]

  • 15. Evidence for multiple sites of regulation of heme synthesis in murine erythroleukemia cells.
    Ebert PS, Bonkowsky HL, Deisseroth A.
    J Natl Cancer Inst; 1979 May 15; 62(5):1247-50. PubMed ID: 155751
    [Abstract] [Full Text] [Related]

  • 16. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M, Boss GR, Pascual FE, Pilz RB.
    Cell Growth Differ; 1995 Dec 15; 6(12):1559-66. PubMed ID: 9019161
    [Abstract] [Full Text] [Related]

  • 17. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells.
    Yamashita T, Eto Y, Shibai H, Ogata E.
    Cancer Res; 1990 Jun 01; 50(11):3182-5. PubMed ID: 2334914
    [Abstract] [Full Text] [Related]

  • 18. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
    Marks PA, Michaeli J, Jackson J, Richon VM, Rifkind RA.
    Prog Clin Biol Res; 1989 Jun 01; 316B():171-81. PubMed ID: 2616574
    [Abstract] [Full Text] [Related]

  • 19. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
    Watanabe T, Sherman M, Shafman T, Iwata T, Kufe D.
    J Cell Physiol; 1986 Jun 01; 127(3):480-4. PubMed ID: 3458709
    [Abstract] [Full Text] [Related]

  • 20. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
    Tsiftsoglou AS, Wong W.
    Anticancer Res; 1985 Jun 01; 5(1):81-99. PubMed ID: 3888045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.